# Early Amiodarone in Shockable Cardiac Arrest

Study · id `cardio:ct-nct06680869` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06680869](<https://clinicaltrials.gov/study/NCT06680869>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06680869

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 585 participants.

## Technical summary

Registry record NCT06680869. Randomized; no masking; primary purpose treatment. Start 2025-01-01 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 585 participants (planned count; ClinicalTrials.gov record NCT06680869, source copy `cardio:ctgov-nct06680869-2025-12-19`, retrieved 2026-10-26)
- Started: 2025-01-01 (actual) (ClinicalTrials.gov record NCT06680869, source copy `cardio:ctgov-nct06680869-2025-12-19`, retrieved 2026-10-26)
- Primary completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT06680869, source copy `cardio:ctgov-nct06680869-2025-12-19`, retrieved 2026-10-26)
- Completion: 2028-01-31 (anticipated) (ClinicalTrials.gov record NCT06680869, source copy `cardio:ctgov-nct06680869-2025-12-19`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT06680869, source copy `cardio:ctgov-nct06680869-2025-12-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06680869-2025-12-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Early Amiodarone in Shockable Cardiac Arrest
- Acronym: Early-Amio
- Condition: Cardiac Arrest
- Intervention (Drug): Amiodarone Hydrochloride Injection
- Intervention (Other): Usual Care Protocol
- Lead sponsor: Oregon Health and Science University
- Lead sponsor class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Amiodarone (`cardio:amiodarone`)
- Registry lists this organization as the lead sponsor: Oregon Health and Science University (`cardio:org-oregon-health-and-science-university`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)

## Provenance

Content hash: 0d6eb12a3e091f6e4ad727648aa14c6af392c9cdb8c8e446059bc1b687a0f27f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
